< 0 1 0 1 O
18 1 3 1 3 B-lower_bound
years 4 9 4 9 O
of 10 12 10 12 O
age 13 16 13 16 B-age

Adequate 0 8 17 25 O
marrow 9 15 26 32 O
and 16 19 33 36 O
hepatic 20 27 37 44 O
function 28 36 45 53 O
defined 37 44 54 61 O
as 45 47 62 64 O
Hgb 48 51 65 68 B-clinical_variable
≥8 52 54 69 71 O
; 54 55 71 72 O
platelets 56 65 73 82 B-clinical_variable
≥100k 66 71 83 88 O
; 71 72 88 89 O
ANC≥1500 73 81 90 98 B-clinical_variable
; 81 82 98 99 O
LFTs 83 87 100 104 B-clinical_variable
≤2x 88 91 105 108 O
upper 92 97 109 114 I-upper_bound
limit 98 103 115 120 I-upper_bound
of 104 106 121 123 I-upper_bound
normal 107 113 124 130 I-upper_bound
and 114 117 131 134 O
creatinine 118 128 135 145 B-clinical_variable
≤1.3 129 133 146 150 O
or 134 136 151 153 O
creatinine 137 147 154 164 B-clinical_variable
clearance 148 157 165 174 I-clinical_variable
of 158 160 175 177 O
≥50 161 164 178 181 O

Concurrent 0 10 182 192 O
chemotherapy 11 23 193 205 B-treatment
is 24 26 206 208 O
allowed 27 34 209 216 O
, 34 35 216 217 O
but 36 39 218 221 O
not 40 43 222 225 O
required 44 52 226 234 O

For 0 3 235 238 O
patients 4 12 239 247 O
undergoing 13 23 248 258 O
SABR 24 28 259 263 B-treatment
, 28 29 263 264 O
both 30 34 265 269 O
early 35 40 270 275 O
stage 41 46 276 281 O
primary 47 54 282 289 B-cancer
lung 55 59 290 294 I-cancer
cancer 60 66 295 301 I-cancer
patients 67 75 302 310 O
and 76 79 311 314 O
those 80 85 315 320 O
with 86 90 321 325 O
limited 91 98 326 333 O
metastatic 99 109 334 344 B-cancer
disease 110 117 345 352 I-cancer
to 118 120 353 355 O
the 121 124 356 359 O
lungs 125 130 360 365 O
are 131 134 366 369 O
eligible 135 143 370 378 O
; 143 144 378 379 O
however 145 152 380 387 O
, 152 153 387 388 O
patients 154 162 389 397 O
with 163 167 398 402 O
oligometastatic 168 183 403 418 B-cancer
disease 184 191 419 426 I-cancer
should 192 198 427 433 O
have 199 203 434 438 O
a 204 205 439 440 O
controlled 206 216 441 451 O
primary 217 224 452 459 O
and 225 228 460 463 O
no 229 231 464 466 O
more 232 236 467 471 O
than 237 241 472 476 O
one 242 245 477 480 O
other 246 251 481 486 O
involved 252 260 487 495 O
organ 261 266 496 501 O
system 267 273 502 508 O

For 0 3 509 512 O
patients 4 12 513 521 O
undergoing 13 23 522 532 O
definitive 24 34 533 543 O
CFRT 35 39 544 548 B-treatment
, 39 40 548 549 O
patients 41 49 550 558 O
with 50 54 559 563 O
distant 55 62 564 571 B-cancer
metastatic 63 73 572 582 I-cancer
disease 74 81 583 590 I-cancer

Life 0 4 591 595 B-clinical_variable
expectancy 5 15 596 606 I-clinical_variable
with 16 20 607 611 O
treatment 21 30 612 621 B-treatment
should 31 37 622 628 O
be 38 40 629 631 O
≥6 41 43 632 634 O
months 44 50 635 641 I-lower_bound
in 51 53 642 644 O
the 54 57 645 648 O
estimation 58 68 649 659 O
of 69 71 660 662 O
the 72 75 663 666 O
treating 76 84 667 675 O
physicians 85 95 676 686 O

Patients 0 8 687 695 O
must 9 13 696 700 O
be 14 16 701 703 O
≥18 17 20 704 707 O
years 21 26 708 713 I-lower_bound
of 27 29 714 716 O
age 30 33 717 720 B-age

Primary 0 7 721 728 B-cancer
lung 8 12 729 733 I-cancer
cancer 13 19 734 740 I-cancer
or 20 22 741 743 I-cancer
metastatic 23 33 744 754 I-cancer
disease 34 41 755 762 I-cancer
to 42 44 763 765 I-cancer
the 45 48 766 769 I-cancer
lungs 49 54 770 775 I-cancer
to 55 57 776 778 O
be 58 60 779 781 O
treated 61 68 782 789 O
with 69 73 790 794 O
either 74 80 795 801 O
conventionally 81 95 802 816 B-treatment
- 95 96 816 817 I-treatment
fractionated 96 108 817 829 I-treatment
radiotherapy 109 121 830 842 I-treatment
( 122 123 843 844 I-treatment
CFRT 123 127 844 848 I-treatment
) 127 128 848 849 I-treatment
or 129 131 850 852 O
hypo 132 136 853 857 B-treatment
- 136 137 857 858 I-treatment
fractionated 137 149 858 870 I-treatment
stereotactic 150 162 871 883 I-treatment
ablative 163 171 884 892 I-treatment
radiotherapy 172 184 893 905 I-treatment
( 185 186 906 907 I-treatment
SABR 186 190 907 911 I-treatment
) 190 191 911 912 I-treatment

Prior 0 5 913 918 B-treatment
radiotherapy 6 18 919 931 I-treatment
for 19 22 932 935 O
thoracic 23 31 936 944 B-cancer
cancer 32 38 945 951 I-cancer
or 39 41 952 954 O
other 42 47 955 960 O
malignancy 48 58 961 971 B-cancer
leading 59 66 972 979 O
to 67 69 980 982 O
any 70 73 983 986 O
overlap 74 81 987 994 O
of 82 84 995 997 O
planned 85 92 998 1005 O
radiotherapy 93 105 1006 1018 O
fields 106 112 1019 1025 O

Zubrod 0 6 1026 1032 B-clinical_variable
performance 7 18 1033 1044 I-clinical_variable
status 19 25 1045 1051 I-clinical_variable
≤2 26 28 1052 1054 O

pregnant 0 8 1055 1063 B-pregnancy
women 9 14 1064 1069 B-gender

